Shares of Waystar Holding Corp. (NASDAQ:WAY – Get Free Report) have earned a consensus rating of “Buy” from the sixteen analysts that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $46.6429.
WAY has been the topic of several recent research reports. The Goldman Sachs Group set a $44.00 price target on shares of Waystar in a research report on Wednesday, January 14th. Wells Fargo & Company assumed coverage on Waystar in a research report on Thursday, January 8th. They set an “overweight” rating and a $41.00 target price on the stock. BMO Capital Markets assumed coverage on Waystar in a research report on Thursday, November 13th. They issued an “outperform” rating and a $47.00 price target for the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waystar in a research report on Wednesday, January 21st. Finally, Citigroup reduced their target price on shares of Waystar from $49.00 to $46.00 and set a “buy” rating for the company in a report on Friday, January 9th.
Check Out Our Latest Analysis on Waystar
Waystar Stock Performance
Insider Activity
In related news, insider Eric L. (Ric) Sinclair III sold 40,225 shares of Waystar stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $30.08, for a total transaction of $1,209,968.00. Following the transaction, the insider owned 474,826 shares in the company, valued at approximately $14,282,766.08. The trade was a 7.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CMO Melissa F. (Missy) Miller sold 3,400 shares of the company’s stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $37.00, for a total transaction of $125,800.00. Following the completion of the transaction, the chief marketing officer directly owned 193,261 shares of the company’s stock, valued at $7,150,657. This represents a 1.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 80,273 shares of company stock worth $2,569,997 in the last three months. Company insiders own 4.10% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in WAY. Salomon & Ludwin LLC bought a new stake in shares of Waystar during the third quarter valued at approximately $25,000. ANTIPODES PARTNERS Ltd grew its stake in Waystar by 120.1% during the third quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock valued at $31,000 after acquiring an additional 449 shares in the last quarter. First Horizon Corp purchased a new position in Waystar during the third quarter valued at $38,000. Nisa Investment Advisors LLC increased its holdings in Waystar by 50.6% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,065 shares of the company’s stock valued at $44,000 after acquiring an additional 358 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in Waystar by 3,219.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock worth $57,000 after purchasing an additional 1,352 shares in the last quarter.
About Waystar
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Featured Articles
- Five stocks we like better than Waystar
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy This Stock at 9:30 AM on MONDAY!
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
